Literature DB >> 6527231

Pharmacokinetics of ibuprofen in man IV: absorption and disposition.

J G Wagner, K S Albert, G J Szpunar, G F Lockwood.   

Abstract

Fifteen normal male volunteers received 400, 800, and 1200 mg doses of ibuprofen as 1, 2, or 3 tablets, respectively, in crossover fashion, then 420 mg in solution form during the fourth week. Plasma concentration of ibuprofen was measured by an HPLC method. Individual subject concentration-time (C,t) data following the solution were analyzed by two different methods, and results unequivocally indicated the open two compartment model with first order absorption. However, the computer fitting of both arithmetic and geometric mean concentrations led to a different model. A method was developed to obtain absorption data (fraction of drug absorbed, Fa, versus time) for a multicompartmental system from oral data alone, without intravenous data. The method assumes that Vp is constant intrasubject and that absorption is complete following administration of both the solution and tablets. The method was successfully applied to the ibuprofen tablet data. It was shown also that such a method is necessary to obtain ibuprofen absorption data since intrasubject variation of the microscopic rate constants k12, k21, and kel (as reflected by the intrasubject variation of the hybrid rate parameters lambda 1 and lambda 2 or beta and alpha) is of the same order of magnitude as intersubject variation. Absorption of ibuprofen from tablets was shown not to be simple first order as for the solution. The absorption profiles following one tablet were S-shaped, while those following 2 or 3 tablets had partial linear segments indicating zero order absorption.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6527231     DOI: 10.1007/bf01062664

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  22 in total

1.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

2.  Determination of some anti-inflammatory drugs in serum by high-performance liquid chromatography.

Authors:  L J Dusci; L P Hackett
Journal:  J Chromatogr       Date:  1979-04-21

3.  Pharmacokinetics of ibuprofen in man--III: Plasma protein binding.

Authors:  G F Lockwood; K S Albert; G J Szpunar; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1983-10

4.  Pharmacokinetic absorption plots from oral data alone or oral/intravenous data and an exact Loo-Riegelman equation.

Authors:  J G Wagner
Journal:  J Pharm Sci       Date:  1983-07       Impact factor: 3.534

5.  Electron-capture GLC determination of ibuprofen in serum.

Authors:  D G Kaiser; R S Martin
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

6.  High-pressure liquid chromatographic determination of ibuprofen in plasma.

Authors:  A Ali; S Kazmi; F M Plakogiannis
Journal:  J Pharm Sci       Date:  1981-08       Impact factor: 3.534

Review 7.  Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disorders.

Authors:  E F Davies; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

8.  GLC determination of ibuprofen ((plus or minus)-2-(p-isobutylphenyl)propionic acid) in plasma.

Authors:  D G Kaiser; G J Vangiessen
Journal:  J Pharm Sci       Date:  1974-02       Impact factor: 3.534

9.  Determination of flurbiprofen and ibuprofen in dog serum with automated sample preparation.

Authors:  B G Snider; L J Beaubien; D J Sears; P D Rahn
Journal:  J Pharm Sci       Date:  1981-12       Impact factor: 3.534

10.  Determination of ibuprofen in serum by high-performance liquid chromatography and application to ibuprofen disposition.

Authors:  G L Kearns; J T Wilson
Journal:  J Chromatogr       Date:  1981-11-13
View more
  6 in total

1.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 3.  Using pharmacokinetic principles to optimize pain therapy.

Authors:  Kay Brune; Bertold Renner; Burkhard Hinz
Journal:  Nat Rev Rheumatol       Date:  2010-09-07       Impact factor: 20.543

4.  Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution.

Authors:  Alex Yu; Mark J Koenigsknecht; Bart Hens; Jason R Baker; Bo Wen; Trachette L Jackson; Manjunath P Pai; William Hasler; Gordon L Amidon; Duxin Sun
Journal:  AAPS J       Date:  2019-11-11       Impact factor: 4.009

5.  Impact of ibuprofen and peroxisome proliferator-activated receptor gamma on emotion-related neural activation: A randomized, placebo-controlled trial.

Authors:  Kelly T Cosgrove; Rayus Kuplicki; Jonathan Savitz; Kaiping Burrows; W Kyle Simmons; Sahib S Khalsa; T Kent Teague; Robin L Aupperle; Martin P Paulus
Journal:  Brain Behav Immun       Date:  2021-05-27       Impact factor: 19.227

6.  Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial.

Authors:  Tine Iskov Kopp; Ditte Marie Jensen; Gitte Ravn-Haren; Arieh Cohen; Helle Molgaard Sommer; Lars Ove Dragsted; Anne Tjonneland; David Michael Hougaard; Ulla Vogel
Journal:  BMC Cancer       Date:  2016-04-21       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.